123 related articles for article (PubMed ID: 15277568)
1. Polymorphonuclear leukocytes from patients with severe sepsis have lost the ability to degrade fibrin via u-PA.
Moir E; Greaves M; Adey GD; Bennett B
J Leukoc Biol; 2004 Sep; 76(3):571-6. PubMed ID: 15277568
[TBL] [Abstract][Full Text] [Related]
2. Polymorphonuclear leucocytes have two opposing roles in fibrinolysis.
Moir E; Robbie LA; Bennett B; Booth NA
Thromb Haemost; 2002 Jun; 87(6):1006-10. PubMed ID: 12083479
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.
Paloma MJ; Páramo JA; Rocha E
Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240
[TBL] [Abstract][Full Text] [Related]
4. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
5. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin.
Ritchie H; Robbie LA; Kinghorn S; Exley R; Booth NA
Thromb Haemost; 1999 Jan; 81(1):96-103. PubMed ID: 10348718
[TBL] [Abstract][Full Text] [Related]
6. Degradation of cross-linked fibrin by leukocyte elastase as alternative pathway for plasmin-mediated fibrinolysis in sepsis-induced disseminated intravascular coagulation.
Madoiwa S; Tanaka H; Nagahama Y; Dokai M; Kashiwakura Y; Ishiwata A; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
Thromb Res; 2011 Apr; 127(4):349-55. PubMed ID: 21236472
[TBL] [Abstract][Full Text] [Related]
7. [Tissue plasminogen activator (t-PA) and urokinase plasminogen activator (u-PA)].
Kondo S
Nihon Rinsho; 2004 Dec; 62 Suppl 12():700-2. PubMed ID: 15658428
[No Abstract] [Full Text] [Related]
8. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis.
Robbie LA; Dummer S; Booth NA; Adey GD; Bennett B
Br J Haematol; 2000 May; 109(2):342-8. PubMed ID: 10848822
[TBL] [Abstract][Full Text] [Related]
9. Influence of homocysteine on fibrin network lysis.
Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
[TBL] [Abstract][Full Text] [Related]
10. Global fibrinolytic capacity in pediatric patients with sepsis and disseminated intravascular coagulation.
Bay A; Oner AF; Kose D; Dogan M
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):569-73. PubMed ID: 16988553
[TBL] [Abstract][Full Text] [Related]
11. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
12. Sepsis, thrombosis and organ dysfunction.
Semeraro N; Ammollo CT; Semeraro F; Colucci M
Thromb Res; 2012 Mar; 129(3):290-5. PubMed ID: 22061311
[TBL] [Abstract][Full Text] [Related]
13. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients.
Haj MA; Robbie LA; Adey GD; Bennett B
Thromb Haemost; 1995 Dec; 74(6):1528-32. PubMed ID: 8772232
[TBL] [Abstract][Full Text] [Related]
15. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
[TBL] [Abstract][Full Text] [Related]
16. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation.
Sivula M; Pettilä V; Niemi TT; Varpula M; Kuitunen AH
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):419-26. PubMed ID: 19581801
[TBL] [Abstract][Full Text] [Related]
17. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
18. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
[TBL] [Abstract][Full Text] [Related]
19. Disseminated intravascular coagulation: What's new?
Levi M
Crit Care Clin; 2005 Jul; 21(3):449-67. PubMed ID: 15992667
[TBL] [Abstract][Full Text] [Related]
20. Images in clinical medicine. Toxic neutrophils in Streptococcus pneumoniae sepsis.
Hann CL; Schmidt EP
N Engl J Med; 2004 Dec; 351(25):2636. PubMed ID: 15602024
[No Abstract] [Full Text] [Related]
[Next] [New Search]